Inventor · disambiguated record
Yasunobu Tanaka
Also filed as: TANAKA YASUNOBU
22 granted patents·17 pending applications·245 citations·filing 2003–2019
96Inventor score
Top patents by PatentIndex Score
39 records- 0196US9393315B2Compounds for targeting drug delivery and enhancing siRNA activityNIITSU YOSHIRO·Filed 2012·Granted Jul 19, 2016·12 cites·17 claims
- 0296US9011903B2Cationic lipids for therapeutic agent delivery formulationsNIITSU YOSHIRO·Filed 2012·Granted Apr 21, 2015·26 cites·23 claims
- 0395US9963424B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2016·Granted May 8, 2018·8 cites·18 claims
- 0495US9242001B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2014·Granted Jan 26, 2016·14 cites·29 claims
- 0595US8741867B2Retinoid-liposomes for treating fibrosisNIITSU YOSHIRO·Filed 2012·Granted Jun 3, 2014·34 cites·29 claims
- 0695US8664376B2Retinoid-liposomes for enhancing modulation of HSP47 expressionNIITSU YOSHIRO·Filed 2012·Granted Mar 4, 2014·30 cites·26 claims
- 0793US10196637B2Retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·7 cites·20 claims
- 0893US9206424B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2014·Granted Dec 8, 2015·21 cites·33 claims
- 0993US7700541B2Biodegradable cationic polymersNITTO DENKO CORP·Filed 2007·Granted Apr 20, 2010·21 cites·23 claims
- 1091US10100004B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Oct 16, 2018·4 cites·10 claims
- 1190US11084779B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2019·Granted Aug 10, 2021·2 cites·40 claims
- 1290US8710209B2Modulation of HSP47 expressionJIN XIAOMEI·Filed 2010·Granted Apr 29, 2014·22 cites·37 claims
- 1389US9456984B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2014·Granted Oct 4, 2016·10 cites·58 claims
- 1488US8216558B2Polymer coating of cellsVAN SANG·Filed 2010·Granted Jul 10, 2012·5 cites·12 claims
- 1587US10000447B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2016·Granted Jun 19, 2018·2 cites·16 claims
- 1687US8574623B2Therapeutic agent for pulmonary fibrosisNITTO DENKO CORP·Filed 2012·Granted Nov 5, 2013·8 cites·6 claims
- 1786US10093923B2Modulation of HSP47 expressionNITTO DENKO CORP·Filed 2015·Granted Oct 9, 2018·5 cites·35 claims
- 1885US10195145B2Method for treating fibrosis using siRNA and a retinoid-lipid drug carrierNITTO DENKO CORP·Filed 2016·Granted Feb 5, 2019·4 cites·31 claims
- 1983US7674452B2Polymer coating of cellsNITTO DENKO CORP·Filed 2006·Granted Mar 9, 2010·4 cites·11 claims
- 2079US7125709B2Culture device and method for eukaryotic cell transfectionNITTO DENKO CORP·Filed 2004·Granted Oct 24, 2006·6 cites·46 claims
- 2172US10669229B2Compounds for targeting drug delivery and enhancing siRNA activityNITTO DENKO CORP·Filed 2018·Granted Jun 2, 2020·0 cites·21 claims
- 2271US10532975B2Cationic lipids for therapeutic agent delivery formulationsNITTO DENKO CORP·Filed 2018·Granted Jan 14, 2020·0 cites·35 claims
- 2353US2008312174A1Water soluble crosslinked polymersNITTO DENKO CORP·Filed 2008·Application pending·0 cites
- 2452US2012269886A1Therapeutic agent for pulmonary fibrosisNIITSU YOSHIRO·Filed 2012·Application pending·0 cites
- 2551US2014323550A1Intestinal fibrosis treatment agentNITTO DENKO CORP·Filed 2012·Application pending·0 cites
- 2650US2017314021A1Agent for treating fibrosis of the intestineNITTO DENKO CORP·Filed 2017·Application pending·0 cites
- 2750US2013011336A1Imaging agents of fibrotic diseasesNITTO DENKO CORP·Filed 2009·Application pending·0 cites
- 2850US2013210744A1Targeting agent for cancer cell or cancer-associated fibroblastNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 2950US2005208295A1Adhesive sheet and kit for microbial testing of solid surfaceFUJI ELECTRIC SYSTEMS CO LTD·Filed 2003·Application pending·0 cites
- 3050US2013171240A1Drug carrier and drug carrier kit for inhibiting fibrosisNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 3147US2013030034A9Modulation of timp1 and timp2 expressionQUARK PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3247US2016015656A2Composition for regenerating normal tissue from fibrotic tissueNITTO DENKO CORP·Filed 2013·Application pending·0 cites
- 3346US2016175446A1Agent for treating fibrosis of the intestineNITTO DENKO CORP·Filed 2016·Application pending·0 cites
- 3444US2016281083A1Modulation of timp1 and timp2 expressionNITTO DENKO CORP·Filed 2015·Application pending·0 cites
- 3540US2006148028A1Method for detecting microbe or cellNODA NAOHIRO·Filed 2003·Application pending·0 cites
- 3640US2013136789A1Agent for treating renal fibrosisNIITSU YOSHIRO·Filed 2011·Application pending·0 cites
- 3739US2007269891A9Solid surface with immobilized degradable cationic polymer for transfecting eukaryotic cellsTANAKA YASUNOBU·Filed 2005·Application pending·0 cites
- 3837US2006073470A1Method of counting microorganisms or cellsNODA NAOHIRO·Filed 2003·Application pending·0 cites
- 3935US2015259683A1Agent for treating renal fibrosisNITTO DENKO CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasunobu Tanaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →